127 related articles for article (PubMed ID: 1450443)
1. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine.
Taylor CW; Yeoman LC
Anticancer Drugs; 1992 Oct; 3(5):485-91. PubMed ID: 1450443
[TBL] [Abstract][Full Text] [Related]
2. Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumour cell lines.
Borsellino N; Crescimanno M; Leonardi V; D'Alessandro N
Pharmacol Res; 1994 Jul; 30(1):81-90. PubMed ID: 7831198
[TBL] [Abstract][Full Text] [Related]
3. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
Carlson CC; Chinery R; Burnham LL; Dransfield DT
Neoplasia; 2000; 2(5):441-8. PubMed ID: 11191111
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
Lamb D; Steinberg RA
J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-Cl-cyclic AMP.
Han Z; Chatterjee D; Wyche JH
J Pharmacol Exp Ther; 1993 May; 265(2):790-4. PubMed ID: 8388460
[TBL] [Abstract][Full Text] [Related]
6. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.
Gandhi V; Ayres M; Halgren RG; Krett NL; Newman RA; Rosen ST
Cancer Res; 2001 Jul; 61(14):5474-9. PubMed ID: 11454694
[TBL] [Abstract][Full Text] [Related]
7. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
Lange-Carter CA; Vuillequez JJ; Malkinson AM
Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
[TBL] [Abstract][Full Text] [Related]
8. 8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs.
Robbins SK; Houlbrook S; Priddle JD; Harris AL
Cancer Chemother Pharmacol; 2001 Dec; 48(6):451-8. PubMed ID: 11800025
[TBL] [Abstract][Full Text] [Related]
9. 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: protein kinase C activation and cyclin B down-regulation.
Ahn YH; Jung JM; Hong SH
J Cell Physiol; 2004 Nov; 201(2):277-85. PubMed ID: 15334662
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.
Langeveld CH; Jongenelen CA; Heimans JJ; Stoof JC
Cancer Res; 1992 Jul; 52(14):3994-9. PubMed ID: 1617676
[TBL] [Abstract][Full Text] [Related]
11. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.
Ahn YH; Jung JM; Hong SH
Cancer Res; 2005 Jun; 65(11):4896-901. PubMed ID: 15930311
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of 8-Cl-cAMP action.
Juranić Z; Radulović S; Joksimović J; Juranić I
J Exp Clin Cancer Res; 1998 Sep; 17(3):269-75. PubMed ID: 9894761
[TBL] [Abstract][Full Text] [Related]
13. 8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine.
Halgren RG; Traynor AE; Pillay S; Zell JL; Heller KF; Krett NL; Rosen ST
Blood; 1998 Oct; 92(8):2893-8. PubMed ID: 9763575
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray.
Park GH; Choe J; Choo HJ; Park YG; Sohn J; Kim MK
Exp Mol Med; 2002 Jul; 34(3):184-93. PubMed ID: 12216110
[TBL] [Abstract][Full Text] [Related]
15. 8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNFalpha-induced apoptosis is via inactivation of NF-kappaB.
Yin Y; Allen PD; Jia L; Kelsey SM; Newland AC
Leuk Res; 2001 May; 25(5):423-31. PubMed ID: 11301111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice.
Cummings J; Langdon SP; Ritchie AA; Burns DJ; Mackay J; Stockman P; Leonard RC; Miller WR
Ann Oncol; 1996 Mar; 7(3):291-6. PubMed ID: 8740794
[TBL] [Abstract][Full Text] [Related]
17. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
Noguchi K; Murata T; Cho-Chung YS
Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
Tagliaferri P; Katsaros D; Clair T; Ally S; Tortora G; Neckers L; Rubalcava B; Parandoosh Z; Chang YA; Revankar GR
Cancer Res; 1988 Mar; 48(6):1642-50. PubMed ID: 2830966
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP.
Bosanquet AG; Burlton AR; Bell PB; Harris AL
Br J Cancer; 1997; 76(4):511-8. PubMed ID: 9275029
[TBL] [Abstract][Full Text] [Related]
20. Sensitive determination of 8-chloroadenosine 3',5'-monophosphate and 8-chloroadenosine in plasma by high-performance liquid chromatography.
Cummings J; Leonard RC; Miller WR
J Chromatogr B Biomed Appl; 1994 Aug; 658(1):183-8. PubMed ID: 7952122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
